It is a pharma private limited company based in Shahdara, Delhi, India, established in 2009.
2009 | Shahdara, Delhi, India | ActiveGrownbury Pharmaceuticals Private Limited, a active private limited company, was established on 18 December 2009 in Shahdara, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24100DL2009PTC197118. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.50 Cr and a paid-up capital of ₹1.14 Cr.
It upholds a compliant status. Its leadership includes Rajeev Sharma (Managing Director), Renu Sharma (Director). Past directors included Rajeev Sharma, Renu Sharma. It holds ₹5.05 Cr open charges and ₹1.15 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at A-15-A, G/F, Jitar Nagar, Krishan Nagar, Main Parwana Road, Shahdara, Delhi, 110051.
U24100DL2009PTC197118
197118
18 December 2009
₹1.50 Cr
₹1.14 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Grownbury Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajeev Sharma | Managing Director | 18 Dec 2009 | Current |
| Renu Sharma | Director | 18 Dec 2009 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 31 Jan 2025 | Past |
| Pramod Abcsdd | Director | 31 Jan 2025 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Grownbury Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 22.38% increase. The company also saw a substantial improvement in profitability, with a 30.18% increase in profit. The company's net worth Soared by an impressive increase of 32.5%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Grownbury Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹50,520,000.00
₹11,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Mar 2017 | Idbi Bank Limited | ₹5.05 Cr | Open |
| 21 Jan 2012 | Vijaya Bank | ₹9.00 M | Satisfied |
| 26 Apr 2011 | Vijaya Bank | ₹2.50 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Grownbury Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Grownbury Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Grownbury Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Grownbury Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Grownbury Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
A charge with Idbi Bank Limited of Rs. 5.05 Cr registered on 01 Mar 2017 with Charge ID 100080815 was modified on 21 Sep 2022. was recorded as a recent event.
Progress on A charge with Idbi Bank Limited amounted to Rs. 5.05 Cr with Charge ID 100080815 was registered on 01 Mar 2017. was documented.
Progress on A charge registered on 21 Jan 2012 via Charge ID 10336482 with Vijaya Bank was fully satisfied on 01 Feb 2017. was documented.
A charge registered on 26 Apr 2011 via Charge ID 10291529 with Vijaya Bank was fully satisfied on 01 Feb 2017. was recorded as a recent event.
The CIN of Grownbury Pharmaceuticals Private Limited is U24100DL2009PTC197118.
Grownbury Pharmaceuticals Private Limited is headquartered at A-15-A, G/F, Jitar Nagar, Krishan Nagar, Main Parwana Road, Shahdara, Delhi, 110051.
Grownbury Pharmaceuticals Private Limited was incorporated on 18 December 2009.
The current directors of Grownbury Pharmaceuticals Private Limited are
The primary industry of Grownbury Pharmaceuticals Private Limited is Trade.
Grownbury Pharmaceuticals Private Limited is unlisted.
The authorized capital of Grownbury Pharmaceuticals Private Limited is ₹1.50 Cr, and the paid-up capital is ₹1.14 Cr.
The compliance status of Grownbury Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX